SATONAZAL Trademark
SATONAZAL is a USPTO trademark filed by SATO PHARMACEUTICAL CO., LTD.. Status: Pending.
Prosecution Summary
Trademark Summary
SATONAZAL is a standard character mark covering nasal sprays for medical purposes, nasal drops for treating allergies, decongestant nasal sprays, and nasal cleaning preparations for medical purposes in International Class 005, along with additional domestic classes 006, 018, 044, 046, 051, and 052. The application is on the Principal Register under intent-to-use basis and currently awaits a statement of use after a fourth extension of time was granted on October 23, 2025. Owner is SATO PHARMACEUTICAL CO., LTD., a Japanese limited company based in Tokyo. No legal proceedings or oppositions are active.
Recent Activity
Filed December 6, 2022, the mark was approved for publication on September 15, 2023, published for opposition October 24, 2023, and r
Trademark Facts
| Mark | SATONAZAL |
|---|---|
| Serial Number | 97705198 |
| Status | Pending |
| Filing Date | 2022-12-06 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | SATO PHARMACEUTICAL CO., LTD. |
| Attorney of Record | Erica R. Halstead |
| Prosecution Events | 25 |
| Latest Event | EEXT on 2026-04-24 |
Goods & Services
Nasal sprays for medical purposes; nasal drops for the treatment of allergies; decongestant nasal sprays; nasal cleaning preparations for medical purposes